Gallium Citrate Ga 67

   
Google
 
Web NewDrugInformation.com

Gallium Citrate Ga 67


Drug - Gallium Citrate Ga 67
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Gallium Citrate, Ga-67
Multiple ingredients are in alphabetical order.

Strength - 2mCi/ML
The potency of the active ingredient(s), Gallium Citrate, Ga-67. May repeat for multiple part products.

Applicant - BRISTOL MYERS SQUIBB
The firm name holding legal responsibility for Gallium Citrate Ga 67. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 017478
The FDA assigned number to Gallium Citrate Ga 67. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Gallium Citrate Ga 67. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - BS
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Gallium Citrate Ga 67 was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Gallium Citrate Ga 67. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Gallium Citrate Ga 67 is in. Format is RX, OTC, DISCN.

Applicant Full Name - Bristol Myers Squibb Medical Imaging
The full name of the firm holding legal responsibility for the new application of Gallium Citrate Ga 67.

Gallium Citrate Ga 67